EBV hazard

Nicholson, Janet (jkn1@CIDHIV7.EM.CDC.GOV)
Thu, 22 Jun 95 12:29:00 EST

According to the biosafety publication from CDC and NIH, EBV should be
handled with BSL2 practices. Though there is little evidence that aerosols
are a significant source of laboratory-acquired infections, it is important
to avoid the creation of aerosols. This is the same recommendation for HIV
and HBV.

Jan Nicholson
CDC
Atlanta, GA

Home Page Table of Contents Sponsors Web Sites
CD ROM Vol 2 was produced by staff at the Purdue University Cytometry Laboratories and distributed free of charge as an educational service to the cytometry community. If you have any comments please direct them to Dr. J. Paul Robinson, Professor & Director, PUCL, Purdue University, West Lafayette, IN 47907. Phone:(317) 494-0757; FAX (317) 494-0517; Web http://www.cyto.purdue.edu EMAIL robinson@flowcyt.cyto.purdue.edu